Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term dosage. Found 18 abstracts

Persky DO, Miller TP, Unger JM, Spier CM, Puvvada S, Stea BD, Press OW, Constine LS, Barton KP, Friedberg JW, LeBlanc M, Fisher RI. Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313. Blood. 2015 Jan 08;125(2):236-41.   PMCID: PMC4287635
Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity. J Clin Oncol. 2014 Jun 20;32(18):1895-901.   PMCID: PMC4050203
Cukierman E, Khan DR. The benefits and challenges associated with the use of drug delivery systems in cancer therapy. Biochemical pharmacology. 2010 Sep;80(5):762-70.   PMCID: PMC2897922
Li L, Quang TS, Gracely EJ, Kim JH, Emrich JG, Yaeger TE, Jenrette JM, Cohen SC, Black P, Brady LW. A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. J Neurosurg. 2010 Aug;113(2):192-8.   PMCID: not NIH funded
Bookman MA, Brady MF, McGuire WP, Harper PG, Alberts DS, Friedlander M, Colombo N, Fowler JM, Argenta PA, De Geest K, Mutch DG, Burger RA, Swart AM, Trimble EL, Accario-Winslow C, Roth LM. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol. 2009 Mar 20;27(9):1419-25.   PMCID: PMC 2668552
Konski A, Li T, Sigurdson E, Cohen SJ, Small W, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys. 2009 May;74(1):55-9.   PMCID: PMC2933375
Plimack ER, Tannir N, Lin E, Bekele BN, Jonasch E. Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures. Cancer. 2009 May;115(9):1859-66.
Schilder RJ, Pathak HB, Lokshin AE, Holloway RW, Alvarez RD, Aghajanian C, Min H, Devarajan K, Ross E, Drescher CW, Godwin AK. Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecol Oncol. 2009 Apr;113(1):21-7.   PMCID: PMC 2741166
Borghaei H, Langer CJ, Millenson M, Ruth KJ, Litwin S, Tuttle H, Seldomridge JS, Rovito M, Mintzer D, Cohen R, Treat J. Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017. J Thorac Oncol. 2008 Nov;3(11):1286-92.
Ozols RF, Bookman MA, du Bois A, Pfisterer J, Reuss A, Young RC. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel. Gynecol Oncol. 2006 Oct;103(1):1-6.
Cohen SJ, Ho L, Ranganathan S, Abbruzzese JL, Alpaugh RK, Beard M, Lewis NL, McLaughlin S, Rogatko A, Perez-Ruixo JJ, Thistle AM, Verhaeghe T, Wang H, Weiner LM, Wright JJ, Hudes GR, Meropol NJ. Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma. J Clin Oncol. 2003 Apr;21(7):1301-6.
Schuchter LM, Hensley ML, Meropol NJ, Winer EP. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2002 Jun 15;20(12):2895-903.
Cianfrocca M, Goldstein LJ. Operable breast cancer. Current treatment options in oncology. 2001 Apr;2(2):157-67.
Guo P, Ma J, Li S, Guo Z, Adams AL, Gallo JM. Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model. Cancer Chemother Pharmacol. 2001 Aug;48(2):169-76.
Sasson AR, Watson JC, Sigurdson ER. Hepatic artery infusional chemotherapy for colorectal liver metastases. Cancer Treat Res. 2001 Jan;109:279-98.
Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292). Cancer. 1999 Jan 15;85(2):290-4.
Langer CJ, Leighton JC, Comis RL, Odwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Ozols RF. Paclitaxel and Carboplatin in Combination in the Treatment of Advanced Non-Small-Cell Lung-Cancer - a Phase-Ii Toxicity, Response, and Survival Analysis. Journal of Clinical Oncology. 1995 Aug;13(8):1860-70.
Ozols RF. Carboplatin and Paclitaxel (Taxol(R)) for the Treatment of Advanced Ovarian-Cancer. International Journal of Gynecological Cancer. 1994 Nov;4:13-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term dosage

dosage drug therapy therapeutic use Female Antineoplastic Combined Chemotherapy Protocols administration & administration & dosage Male Middle Aged Aged pathology administration & Human adverse effects Antineoplastic Agents Adult Disease-Free Survival pharmacokinetics Monoclonal Antibodies Doxorubicin mortality radiotherapy Neoplasm Staging metabolism Fluorouracil Treatment Outcome derivatives Neoadjuvant Therapy chemically induced Deoxycytidine methods Cisplatin Ovarian Neoplasms analogs & Neoplasm Metastasis Carboplatin Combined Modality Therapy Paclitaxel US Gov't Support-PHS Adenocarcinoma pharmacology Young Adult cisplatin chemotherapy secondary Prospective Studies Middle Age Drug Administration Schedule Polyethylene Glycols Disease Progression Epidermal Growth Factor Receptor Brain Neoplasms surgery toxicity Drug Delivery Systems 80 and over Aged Kaplan-Meier Estimate Methotrexate Intravenous Infusions Local Neoplasm Recurrence Neoplasms Peritoneal Neoplasms Adjuvant Chemotherapy Interferon-alpha Protective Agents Chelating Agents Filgrastim Granulocyte Colony-Stimulating Factor Nonparametric Statistics Non-Small-Cell Lung Carcinoma Nude Rats Agranulocytosis Positron-Emission Tomography Proportional Hazards Models Pancreatic Neoplasms Dacarbazine Liver Neoplasms Tumor Biomarkers Carrier Proteins Randomized Controlled Trials as Topic Proteomics Sprague-Dawley Rats genetics Intra-Arterial Infusions Drug Carriers drug effects Prednisone Analysis of Variance Mesna Rectal Neoplasms cooperative-oncology-group Phase III Clinical Trials as Topic Radiotherapy Alkyl and Aryl Transferases Urinary Bladder Neoplasms Practice Guidelines Retrospective Studies Kidney Neoplasms Antineoplastic Antimetabolites Prognosis paclitaxel Recombinant Proteins Cultured Tumor Cells chemistry serum creatinine Liposomes Fluorodeoxyglucose F18 immunology Parenteral Infusions Alkylating Antineoplastic Agents Kaplan-Meiers Estimate Isoquinolines randomized Vinblastine Squamous Cell Carcinoma Drug Dose-Response Relationship Quinolones Stomach Neoplasms Razoxane Neoplasm Invasiveness Vincristine Mitomycin Biological Tumor Markers radionuclide imaging Hormone-Dependent Neoplasms Heat-Shock Proteins Recurrence trial Survival Rate Consolidation Chemotherapy antagonists & inhibitors Tissue Distribution Radiopharmaceuticals Adjuvant Radiotherapy Outcome Assessment (Health Care) Cyclophosphamide Micelles Iodine Radioisotopes phase-iii analysis Hepatic Artery Bronchiolo-Alveolar Adenocarcinoma Animal trials blood supply Acneiform Eruptions Renal Cell Carcinoma analogs & Bone Marrow Tamoxifen
Last updated on Wednesday, February 05, 2020